Combined treatment of genital human papillomavirus infection in men
- Authors: Al'-Shukri S.H1,2, Kuz'min I.V1,2, Slesarevskaya M.N2
-
Affiliations:
- First Pavlov State Medical University
- Scientific Research Institute of Surgery and Emergency Medicine, First Pavlov State Medical University
- Issue: No 6 (2015)
- Pages: 35-39
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/282302
- ID: 282302
Cite item
Open Access
Access granted
Abstract
This study aimed to assess the efficacy of treatment of genital human papillomavirus infection in 107 men. Patients in group 1 (n=51) underwent laser ablation of genital warts, patients in group 2 (n=56) were treated with laser ablation in conjunction with the administration of an immune system medication izoprinozin. During the first 9 months post-treatment, human papillomavirus infection relapse rate in group 1 was 23,5% and in group 2 - 5,4%. It was likewise observed that the combined treatment of genital warts resulted in reduced incidence of infective complications and the time of wound epithelialization after laser papilloma ablation.
Full Text
About the authors
S. H Al'-Shukri
First Pavlov State Medical University; Scientific Research Institute of Surgery and Emergency Medicine, First Pavlov State Medical UniversityDepartment of Urology
I. V Kuz'min
First Pavlov State Medical University; Scientific Research Institute of Surgery and Emergency Medicine, First Pavlov State Medical UniversityDepartment of Urology
M. N Slesarevskaya
Scientific Research Institute of Surgery and Emergency Medicine, First Pavlov State Medical University
Email: mns-1971@yandex.ru
Senior Researcher at Department of Urology
References
- Schellenbacher C., Kwak K., Fink D., Shafti-Keramat S., Huber B., Jindra C., Faust H., Dillner J., Roden R.B., Kirnbauer R. Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses. J. Invest. Dermatol. 2013;133: 2706-2713.
- Рахматулина М.Р. Новые возможности комплексной терапии аногенитальной папилломавирусной инфекции. Вестник дерматологии и венерологии. 2011;2:79-84.
- Wen L. M., Estcourt C. S., Simpson J. M., Mindel A. Risk factors for the acquisition of genital warts: are condoms protective? Sex. Transm. Infect. 1999;75(5):312-316.
- zur Hausen H. Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis. J. Nat. Cancer Inst. 2000;92:690-698.
- Workowski K.A., Berman S. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. 2010;59:1-110.
- Fairley C.K., Donovan B. What can surveillance of genital warts tell us? Sexual Health. 2010;7:325-327.
- Прилепская В.Н., Бебнева Т.Н. Профилактика рака шейки матки: Сухих Г.Т. (ред.) Руководство для врачей под редакцией: М.: МЕДпресс-информ. 2012. С. 26-29.
- Петрова А.С., Агамова К.А., Ермолаева А.Г. Роль и место цитологической диагностики в клинической практике. Клиническая лабораторная диагностика. 1996;4:4-7.
- Frega A., Stentella P., Villani C., Di Ruzza D., Marcomin G.L., Rota F., Boninfante M., Pachi A. Correlation between cervical intraepithelial neoplasia and human papillomavirus male infections: a longitudinal study. Eur. J. Gynaecol. Oncol. 1999;20(3):228-230.
- Кацамбас А.Д., Лотти Т.М. Европейское руководство по лечению дерматологических болезней. М.: МЕДпресс-информ, 2009. С. 84-88.
- Sedlacek T.V. Advances in the diagnosis and treatment of human papillomavirus infection. Clin. Obstet. Gynnecol. 1999;42:206-220.
- Frega A., Stentella P., Villani C., Di Ruzza D., Marcomin G.L., Rota F., Boninfante M., Pachi A. Correlation between cervical intraepithelial neoplasia and human papillomavirus male infections: a longitudinal study. Eur. J. Gynaecol. Oncol. 1999;20:228-230.
- Yang J., Pu Y.G., Zeng Z.M., Yu Z.J., Huang N., Deng Q.W. Interferons for the treatment of genital warts: a systematic review. BMC Infectious Diseases. 2009;9:156.
- Fenton J. Double blind study of the effect of Isoprinosine upon immunity tests in patients with pelvic radiation. Bull. Cancer. 1981;68:200.
- O’Neill B.B., Robins D.S. Isoprinosine in the treatment of genital warts. Cancer Detect. Prev. 1988; 12(1-6): 497-501
- De Simone C., Famularo G., Tzantzoglou S., Moretti S., Jirillo E. Inosine pranobex in the treatment of HIV infection: a review. Int. J. Immunopharmacol. 1991;13:19-27.
- Sadoul G., Beuret T. Treatment of cervical and vulvar condyloma with CO2 laser combined with an immunostimulant [in French]. Revue de Franais Gynecologie et Obstetricque 1984;79(11):681-684.
- Лейзерман М.Г., Лесков И.В., Наседкин А.Н. Старосветский Б.В., Рябова С.В., Шехтер А.Б. Сравнительное изучение радиоволнового, лазерного и ультразвукового воздействия на биологические ткани в эксперименте. Российская ринология. 1999;3:16-18.
- Edwards A. Podophyllotoxin 0.5% v podophylhn 20% to treat penile warts. Genitourim. Med. 1998;64:263-265.
Supplementary files
